Forty-eight trial participants were chosen from a group of non-treatment-seeking adults with AUD
Treatment should not be delayed pending test results if neurological features are present
In late-2024 and early-2025, Big Pharma did a spree of deals (e.g., Bristol-Myers/Sitagliptin for Mirati, Merck/Pfizer in rare diseases, etc.)
While rare, Ozempic can also lead to serious side effects such as pancreatitis, kidney damage, or allergic reactions
Safety Considerations and Contraindications GLP-1 medications have important safety considerations regardless of whether they are FDA-approved or compounded formulations
fMRI studies have shown that ghrelin administration increases activity in brain regions associated with reward and food motivation, meaning it does not just make you feel hungry in an abstract way